MAYTEE BOONYAPREDEE
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology HINSDALE, IL NPI 1235314501
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology IL Mallinckrodt Hospital Products Inc. All categories
General Payments — all program years on this page
$4,510.71
- Category: General Payments
- Program years: PY2018–2024
- Record count: 158
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $892.75 across 34 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $892.75 | 34 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | $183.33 | 5 |
| ANI Pharmaceuticals, Inc. | $80.97 | 3 |
| Retrophin, Inc. | $77.58 | 3 |
| OPKO Pharmaceuticals, LLC | $74.36 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $57.83 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $56.59 | 2 |
| Acerta Pharma LLC | $55.87 | 3 |
| Amgen Inc. | $55.31 | 2 |
| Ardelyx, Inc. | $52.19 | 2 |
| CALLIDITAS THERAPEUTICS US INC. | $47.54 | 2 |
| BARD PERIPHERAL VASCULAR, INC. | $46.59 | 2 |
| Otsuka America Pharmaceutical, Inc. | $27.57 | 1 |
| AKEBIA THERAPEUTICS INC | $22.73 | 1 |
| Lilly USA, LLC | $21.05 | 1 |
| Ultragenyx Pharmaceutical Inc. | $19.07 | 1 |
| GlaxoSmithKline, LLC. | $14.17 | 1 |
By program year
Records — PY2024 (34)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.